This firm-fixed-price purchase order was awarded to Sirtex Medical Inc., a for-profit medical device company, by the Defense Health Agency. The contract is for the supply of SIR-Spheres Y-90 radioactive microspheres, which are used in interventional radiology procedures to treat liver tumors and metastatic disease through internal radiation therapy. The contract has a potential value of $17,750.00 and a completion date of August 1, 2022. The contract does not have a set-aside designation. Sirtex...
This is a firm fixed-price purchase order contract awarded by the Defense Health Agency to Sirtex Medical Inc., a global healthcare company, for the supply of SIR-SPHERES Y-90 resin microspheres. The SIR-Spheres are a targeted radiation therapy used in interventional radiology procedures to treat inoperable primary and metastatic liver tumors, as well as metastatic colorectal cancer to the liver, in veterans and military members. The contract has a potential value of $863,760.00 and a completion...
This contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Sirtex Medical Inc., a global healthcare company that provides medical devices and therapies for cancer treatment. The contract is for the purchase of Y-90 SIR-Spheres, which are resin microspheres used in selective internal radiation therapy to treat inoperable liver tumors and metastatic disease in veterans and military members. The potential value of the contract is $142,000.00, and it has a...
The Department of the Army Medical Command awarded a firm fixed price BPA call contract to Sirtex Medical Inc., a for-profit medical device company, to supply SIR-SPHERES Y-90 resin microspheres. These specialized radioactive microspheres are used in selective internal radiation therapy to treat inoperable liver cancer in veterans and military members. The contract has a potential value of $144,000.00 and a completion date of April 30, 2017. No set-aside designation was used for this award....
This is a firm fixed-price purchase order contract awarded by the Defense Health Agency (DHA) to Sirtex Medical Inc., a for-profit medical technology company specializing in targeted radiation treatments for cancer. The $19,448 contract is for the supply of SIR-Spheres Y-90 resin microspheres, a radioactive medical device used in Selective Internal Radiation Therapy (SIRT) to treat liver tumors and metastatic colorectal cancer. The contract has a period of performance through March 22, 2025...
This firm fixed-price purchase order was awarded by the Department of Veterans Affairs Veterans Health Administration to Sirtex Medical Inc., a global healthcare company, to provide RESIN Y-90 MICROSPHERES with a potential value of $17,300.00. The microspheres, which contain the radioactive isotope Yttrium-90, are used in selective internal radiation therapy to treat inoperable primary and metastatic liver tumors, as well as metastatic colorectal cancer to the liver, in veterans and military...
The Defense Health Agency awarded a firm fixed-price Blanket Purchase Agreement (BPA) call to Sirtex Medical Inc., a global healthcare company, to provide Yttrium-90 (Y90) radioactive microspheres for the treatment of liver cancer. The $172,415.00 contract is for the supply of Sirtex's SIR-Spheres Y-90 resin microspheres and associated medical devices to be used in interventional radiology procedures to treat inoperable primary and metastatic liver tumors, as well as metastatic colorectal cancer...
This federal contract award to Sirtex Medical Inc. is for the delivery of SIR-Spheres Y-90 resin microspheres, a medical device used in selective internal radiation therapy to treat inoperable liver cancer. The contract, awarded by the Defense Health Agency, is a Blanket Purchase Agreement (BPA) call with a firm fixed price of $416,000.00. Sirtex Medical, a global healthcare company, is the prime contractor supplying these specialized radioactive spheres to the VA and DOD healthcare systems. The...
This is a firm fixed-price contract awarded by the Defense Health Agency (DHA) to Sirtex Medical Inc., a medical device manufacturer specializing in cancer therapies. The $320,000.00 contract is for the supply of SIR-Spheres Y-90 resin microspheres, a targeted radiation therapy technology used to treat liver tumors and metastatic colorectal cancer. The contract has no set-aside designation and supports the provision of specialized medical devices and related materials to the Department of...
This is a federal purchase order contract awarded by the Defense Health Agency (DHA) to Sirtex Medical Inc. for the delivery of SIR-Y001 SIR Spheres Y-90 resin microspheres. The $18,345.00 firm fixed-price contract has a period of performance ending on March 31, 2024. The SIR Spheres are used in selective internal radiation therapy to treat inoperable primary and metastatic liver tumors, as well as metastatic colorectal cancer to the liver, in veterans and military members. This contract has...